SCHEMBL9429944

SCHEMBL9429944

CCOC(=O)c1noc(-c2ccccc2)c1C(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
MAPT P10636 2/20 0.53
HTT P42858 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 2/20 0.49
ACR P10323 1/20 0.49
TP53 P04637 2/20 0.48
EPHX2 P34913 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
GPBAR1 Q8TDU6 1/20 0.47
HIF1A Q16665 1/20 0.46
NPC1 O15118 1/20 0.46
GAA P10253 1/20 0.46
RAB9A P51151 1/20 0.46
GHSR Q92847 2/20 0.46
DHODH Q02127 1/20 0.46
PTGS2 P35354 1/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9428463 0.89 KDM4E (0.54) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL9429341 0.87 MAPT (0.58) MAPTHTTTP53SMN1; SMN2NPC1
SCHEMBL9428655 0.86 PTGS2 (0.51) MAPTHTTMEN1KMT2ATP53
SCHEMBL9429043 0.84 HTT (0.65) KDM4EMAPTHTTMEN1KMT2A
SCHEMBL768777 0.80 PTGS1 (0.51) KDM4EMAPTHTTMEN1KMT2A
SCHEMBL2565415 0.78 PTGS1 (0.52) KDM4EMAPTHTTMEN1KMT2A
SCHEMBL9429412 0.78 HIF1A (0.56) KDM4EMAPTALDH1A1TP53SMN1; SMN2
SCHEMBL16110874 0.77 PTGS1 (0.48) KDM4EMAPTHTTMEN1KMT2A
SCHEMBL1686237 0.75 TARBP2 (0.56) KDM4EMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL1686242 0.75 TARBP2 (0.56) KDM4EMAPTALDH1A1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328907-A Treatment of allograft rejection in mammals and antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed